1643 Modern Chinese Medicine Group Co. Ltd. HKEX · China

Modern Chinese Medicine Group Co. (1643) news

Modern Chinese Medicine Group Co. Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1643, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Modern Chinese Medicine Group Co. news

We have not published a story on Modern Chinese Medicine Group Co. yet. When there is news, it will appear here.

Questions about Modern Chinese Medicine Group Co.

What is the ticker symbol of Modern Chinese Medicine Group Co.?

Modern Chinese Medicine Group Co. Ltd. trades under the ticker 1643 on HKEX.

Where is Modern Chinese Medicine Group Co. listed?

Modern Chinese Medicine Group Co. Ltd. is listed on HKEX.

Which country or territory is Modern Chinese Medicine Group Co. listed under?

Our directory records Modern Chinese Medicine Group Co. Ltd. under China.

What does Modern Chinese Medicine Group Co. do?

Our directory classifies Modern Chinese Medicine Group Co. Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Modern Chinese Medicine Group Co.?

The ISIN recorded for Modern Chinese Medicine Group Co. Ltd. is KYG6181B1068.

Does aibio.space cover Modern Chinese Medicine Group Co.?

aibio.space lists Modern Chinese Medicine Group Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Modern Chinese Medicine Group Co.?

Companies in our directory listed in the same country and business area as Modern Chinese Medicine Group Co.: Anhui Sunhere Pharmaceutical Excipients Co., Gansu Longshenrongfa Pharmaceutical Industry Co., Hubei Biocause Heilen Pharmaceutical Co., Yantai Dongcheng Biochemicals Co., China Medicine, Golden Throat Holdings Group Co.

Investor discussion: Modern Chinese Medicine Group Co.

Members talk about Modern Chinese Medicine Group Co. (1643). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Modern Chinese Medicine Group Co., newest first. Each line links the filing it comes from.

Jun 26, 2026Mergers
Transaction under the Listing Rules: MAJOR TRANSACTION IN RELATION TO ACQUISITION OF SALE SHARES. Source
May 7, 2026Mergers
Transaction under the Listing Rules: GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14.41(A) OF THE LISTING RULES AND FURTHER DELAY IN DESPATCH OF CIRCULAR. Source
Apr 30, 2026Mergers
Transaction under the Listing Rules: DELAY IN DESPATCH OF CIRCULAR. Source
Apr 28, 2026Financings
Share or debt issue: PROPOSALS FOR GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; RE-ELECTION OF THE RETIRING DIRECTORS; AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND NOTICE OF ANNUAL GENERAL MEETING. Source
Feb 12, 2026Mergers
Transaction under the Listing Rules: GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14.41(A) OF THE LISTING RULES AND DELAY IN DESPATCH OF CIRCULAR. Source
Feb 9, 2026Mergers
Transaction under the Listing Rules: DELAY IN DESPATCH OF CIRCULAR. Source
Jan 19, 2026Mergers
Transaction under the Listing Rules: MAJOR TRANSACTION ACQUISITION OF SALE SHARES. Source
Jun 5, 2025Financings
Share or debt issue: SUPPLEMENTAL ANNOUNCEMENT SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source
Apr 29, 2025Financings
Share or debt issue: PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES OF THE COMPANY AND PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS AND NOTICE OF THE ANNUAL GENERAL MEETING OF THE COMPANY. Source
Apr 8, 2025Financings
Share or debt issue: SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source

Press releases

Headlines of Modern Chinese Medicine Group Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it.

Oct 21, 2026HKEXnews
TERMINATION OF CONTRACTUAL ARRANGEMENTS
Aug 28, 2026HKEXnews
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026
Aug 21, 2026HKEXnews
PROFIT WARNING
Jun 26, 2026HKEXnews
Documents on Display
Jun 26, 2026HKEXnews
MAJOR TRANSACTION IN RELATION TO ACQUISITION OF SALE SHARES
May 29, 2026HKEXnews
THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
May 29, 2026HKEXnews
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 29 MAY 2026
May 7, 2026HKEXnews
GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14.41(A) OF THE LISTING RULES AND FURTHER DELAY IN DESPATCH OF CIRCULAR
Apr 30, 2026HKEXnews
DELAY IN DESPATCH OF CIRCULAR
Apr 28, 2026HKEXnews
NOTICE OF THE 2026 ANNUAL GENERAL MEETING
Apr 28, 2026HKEXnews
PROPOSALS FOR GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; RE-ELECTION OF THE RETIRING DIRECTORS; AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND NOTICE OF ANNUAL GENERAL MEETING
Apr 28, 2026HKEXnews
PROPOSED AMENDMENTS TO THE EXISTING ARTICLES OF ASSOCIATION AND PROPOSED ADOPTION OF THE NEW ARTICLES OF ASSOCIATION
Apr 17, 2026HKEXnews
SUPPLEMENTAL ANNOUNCEMENT HIGH CONCENTRATION OF SHAREHOLDING
Apr 14, 2026HKEXnews
HIGH CONCENTRATION OF SHAREHOLDING
Apr 14, 2026HKEXnews
SFC ANNOUNCEMENT - HIGH CONCENTRATION OF SHAREHOLDING
Mar 30, 2026HKEXnews
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025
Feb 12, 2026HKEXnews
GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14.41(A) OF THE LISTING RULES AND DELAY IN DESPATCH OF CIRCULAR
Jan 19, 2026HKEXnews
MAJOR TRANSACTION ACQUISITION OF SALE SHARES
Dec 18, 2025HKEXnews
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE 2024 ANNUAL REPORT
Aug 29, 2025HKEXnews
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:1643 on TradingView.

Listing details

Company: Modern Chinese Medicine Group Co. Ltd.
Ticker: 1643
Listing: HKEX
Country or territory: China
Business scope: Pharmaceuticals: Major
ISIN: KYG6181B1068
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction